Practical approach to the patient with hypereosinophilia

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 1, 2010, Pages 39-44

  Roufosse, Florence ^a   Weller, Peter F ^b  

^a ERASME HOSPITAL   (Belgium)

^b Dana Bldg   (United States)

Author keywords

Eosinophils; FIP1L1 PDGFRA; hypereosinophilic syndromes

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; IMATINIB; IVERMECTIN; MEPOLIZUMAB; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYTOIN; VINCRISTINE;

ALLERGIC VASCULITIS; ARTICLE; CHURG STRAUSS SYNDROME; CYTOLOGY; DRESS SYNDROME; DRUG MEGADOSE; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC GASTROENTERITIS; HELMINTHIASIS; HUMAN; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; LOEFFLER PNEUMONIA; NEMATODIASIS; NEPHRITIS; PRIORITY JOURNAL;

EOSINOPHILIA; EOSINOPHILS; HUMANS; HYPEREOSINOPHILIC SYNDROME;

EID: 77954089655     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.04.011     Document Type: Article

References (13)

1. Simon H.-U., Rothenberg M.E., Bochner B.S., Weller P.F., Wardlaw A.J., Wechsler M.E., et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 126 (2010) 45-49
2. Ackerman S.J., and Bochner B.S. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol Allergy Clin North Am 27 (2007) 357-375
3. Blanchard C., and Rothenberg M.E. Biology of the eosinophil. Adv Immunol 101 (2009) 81-121
4. Spencer L.A., Szela C.T., Perez S.A., Kirchhoffer C.L., Neves J.S., Radke A.L., et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol 85 (2009) 117-123
5. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 323 (1990) 1033-1039
6. Chusid M.J., Dale D.C., West B.C., and Wolff S.M. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54 (1975) 1-27
7. Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med 60 (2009) 293-306
8. Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 (2003) 1201-1214
9. Bain B.J., and Fletcher S.H. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am 27 (2007) 377-388
10. Tefferi A., Gotlib J., and Pardanni A. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 85 (2010) 158-164
11. Roufosse F., Cogan E., and Goldman M. Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am 27 (2007) 389-413
12. Ogbogu P.U., Bochner B.S., Butterfield J.H., Gleich G.J., Huss-Marp J., Kahn J.E., et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 124 (2009) 1319-1325
13. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114 (2009) 937-951